Citadel Advisors - APPLIED MOLECULAR TRANS INC ownership

APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 43 filers reported holding APPLIED MOLECULAR TRANS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of APPLIED MOLECULAR TRANS INC
ValueSharesWeighting
Q4 2022$13,388
-96.3%
31,876
-91.5%
0.00%
Q3 2022$364,000
-74.7%
373,862
-24.4%
0.00%
Q2 2022$1,440,000
+8.2%
494,665
+179.4%
0.00%
Q1 2022$1,331,000
-48.9%
177,051
-5.0%
0.00%
-100.0%
Q4 2021$2,605,000
-41.8%
186,332
+7.7%
0.00%0.0%
Q3 2021$4,475,000
-75.2%
173,007
-75.9%
0.00%
-83.3%
Q2 2020$18,034,000717,3300.01%
Other shareholders
APPLIED MOLECULAR TRANS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 3,611,615$567,02470.62%
Founders Fund VI Management, LLC 826,607$129,7770.98%
EPIQ Capital Group, LLC 8,689,075$1,364,1850.71%
GEODE CAPITAL MANAGEMENT, LLC 139,808$21,9490.00%
OSAIC HOLDINGS, INC. 500$780.00%
STATE STREET CORP 55,055$8,6440.00%
NEW YORK STATE COMMON RETIREMENT FUND 650$00.00%
TWO SIGMA INVESTMENTS, LP 49,958$7,8430.00%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 66,207$10,3950.00%
Qube Research & Technologies Ltd 2,104$3300.00%
View complete list of APPLIED MOLECULAR TRANS INC shareholders